cosynthesis

About cosynthesis

Chr. Olesen Synthesis, established in 2011, is a Danish manufacturer specializing in Active Pharmaceutical Ingredients (APIs) and advanced intermediates. The company operates a state-of-the-art production facility located just south of Copenhagen, spanning over 8,000 square meters and equipped with cGMP (current Good Manufacturing Practice) compliant documentation and equipment. This ensures that the products meet stringent quality standards required by the pharmaceutical industry.

Chr. Olesen Synthesis serves a diverse range of clients within the pharmaceutical sector, providing essential components for drug manufacturing. The company operates within the broader market of pharmaceutical ingredients, focusing on delivering high-quality, reliable products that meet the needs of its clients.

The business model of Chr. Olesen Synthesis revolves around the production and sale of APIs and advanced intermediates. Revenue is generated through the manufacturing and distribution of these products to pharmaceutical companies, which use them in the development and production of medications. The company benefits from its affiliation with the Chr. Olesen Group, a global entity with a long history in the feed, food, and pharma ingredients industries, providing a robust network and additional resources.